2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of thePredictive Biomarkers Market from 2025 to 2034?
The predictive biomarkers market is forecasted to experience growth due to the escalating number of cancer patients. Cancer, an illness defined by undisciplined cell development potentially spreading to other body parts, is increasingly seen primarily due to the aging population, alterations in lifestyle, and elevated exposure to high-risk elements like tobacco, unhealthy food habits, and environmental contaminants. Predictive biomarkers in cancer play a significant role in identifying patients who are expected to react positively to specific treatments, thus offering personalized and more efficient therapy. For example, a report from the International Agency for Research on Cancer (IARC), a France-based specialized department of the World Health Organization (WHO) concentrating on cancer research in April 2024, documented nearly 20 million new cancer incidents and around 10 million cancer-associated fatalities in 2022. Furthermore, forecasts predict that the yearly count of fresh cancer cases will escalate to 35 million by 2050, indicating a 77% jump from 2022. Therefore, this surge in cancer incidents is anticipated to fuel the growth of the predictive biomarkers market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20595&type=smp
#What is the Growth Potential of the Predictive Biomarkers Market, and How Will It Perform by 2034?
The market size of predictive biomarkers has seen consistent growth over the past few years. It is projected to expand from $20.05 billion in 2024 to $20.96 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%. The growth observed in the historic period can be traced back to factors such as increased research and development investments, the expansion of healthcare infrastructure, alliances between academia and industry, a rising prevalence of cancer and genetic disorders, and the heightened use of biomarkers in the field of drug development.
The market size for predictive biomarkers is anticipated to undergo substantial growth in the forthcoming years. It is projected to swell to a value of $24.67 billion by 2029, with a compound annual growth rate (CAGR) of 4.2%. This expansion during the forecast period is credited to the growing acceptance of precision medicine, a heightened emphasis on preventive healthcare, increased healthcare spending, higher investments in biomarker-driven diagnostics, growth of biobanks and tissue repositories, and an upsurge in global health consciousness. Key trends throughout the forecast period encompass the inclusion of artificial intelligence in biomarker analysis, the evolution of non-invasive biomarker tests, advances in digital health tools based on biomarkers, progress in single-cell sequencing technologies, the construction of real-time biosensing and monitoring systems, and advancements in bioinformatics tools for data integration.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20595
How Are Market Trends and Innovations Revolutionizing thePredictive Biomarkers Industry in Recent Times?
Big players in the predictive biomarkers market are driving biomarker development forward with the help of advanced technologies, such as AI-based biomarker identification, as a strategy to stay competitive by delivering customized and potent therapies promptly. AI-based biomarker identification has the ability to analyze extensive, complicated datasets, ultimately identifying predictive biomarkers that may not be readily visible with conventional techniques. For instance, in July 2024, US-based precision immunology firm, Scipher Medicine, Inc., established PRoBeNet (Predictive Response Biomarkers using Network Medicine). Its goal is to speed up the creation of predictive response biomarkers for intricate diseases utilizing AI and network biology. PRoBeNet uncovers biomarkers of therapy response by incorporating therapy-targeted proteins and disease-specific molecular signatures. The system has been verified for autoimmune diseases such as rheumatoid arthritis, ulcerative colitis, and Crohn’s disease and has potential applications in other complex diseases and stages of drug development.
Which Key Market Players Are Shaping the Future and Growth of thePredictive Biomarkers Market?
Major companies operating in the predictive biomarkers market are Johnson & Johnson Services Inc, F Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthcare GmbH, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Bio-Rad Laboratories Inc, QIAGEN GmbH, Almac Group Limited, ArcherDX Inc, Luminex Corporation, Guardant Health Inc, Meso Scale Diagnostics LLC, Myriad Genetics Inc, NanoString Technologies Inc, Fujirebio Inc, Asuragen Inc, Biognosys AG, Epigenomics AG, OncoCyte Corporation, Biomarker Technologies Inc
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/predictive-biomarkers-global-market-report
What Are the Core Segments of the Predictive Biomarkers Market, and How Do They Contribute to Growth?
The predictive biomarkers market covered in this report is segmented –
1) By Indication: Cancer, Metabolic Disease, Cardiovascular Disorder, Immunological Disorder, Other Indications
2) By Application: Screening, Analysis, Diagnosis, Prediction, Monitoring
3) By End User: Diagnostic Centers, Contract Research Organizations, Academic Research Institutes, Pharms And Biotech Companies, Other End Users
Subsegments:
1) By Cancer: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer, Leukemia And Lymphoma, Melanoma, Pancreatic Cancer, Kidney Cancer, Head And Neck Cancer
2) By Metabolic Disease: Type 1 and Type 2 Diabetes, Obesity, Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease (NAFLD), Dyslipidemia, Insulin Resistance
3) By Cardiovascular Disorder: Atherosclerosis, Coronary Artery Disease, Heart Failure, Myocardial Infarction (Heart Attack), Arrhythmia, Hypertension, Stroke, Peripheral Arterial Disease
4) By Immunological Disorder: Autoimmune Diseases, Inflammatory Bowel Disease (IBD), Multiple Sclerosis, Psoriasis, Allergic Diseases, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Immunodeficiency Disorders
5) By Other Indications: Neurological Disorders, Infectious Diseases, Renal Diseases, Osteoarthritis, Genetic Disorders, Respiratory Disorders
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20595&type=smp
What Regions Are Dominating the Predictive Biomarkers Market Growth?
North America was the largest region in the predictive biomarkers market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Predictive Biomarkers Market 2025, By The Business Research Company:
Renal Biomarkers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
Renal Biomarkers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report
Cancer Biomarker Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
